Efficacy Analysis of Anti-VEGF Combined Compound Anisodine for Macular Edema Caused by Retinal Vein Occlusion
Download as PDF
DOI: 10.25236/isbsbh.2020.028
Author(s)
Jing Wu, Xuewu Gong, Shuhong Zhang, Xiuhong Wang, Shan Cong
Corresponding Author
Shuhong Zhang
Abstract
Objective: To evaluate the efficacy of compound anisodine injection combined with anti VEGF in the treatment of macular edema due to branch retinal vein occlusion, and to explore the advantages of the combination. Methods: 72 patients with retinal vein occlusion were randomly divided into combined group and control group, 36 cases in each group. The control group was treated with routine anti VEGF injection once, while the combined group was treated with compound anisodine injection at the same time. One injection was given every day for 14 days, rest for 2 days, and then injection for 14 days. The therapeutic effects of the two groups were compared. Results: compared with the control group and the combined group, the difference of corrected vision was statistically significant at different time points before and after injection, and the improvement of corrected vision at the 30th and 90th day after combined treatment was significantly different from that of the control group (P < 0.05). Conclusion: Compound anisodine combined with anti VEGF drugs can improve the therapeutic effect on macular edema patients with retinal vein occlusion.
Keywords
Anti-VEGF combined compound anisodine, Macular edema, Retinal vein occlusion